S2348 Exposure-Response Analysis of Open Label Tradipitant in Idiopathic and Diabetic Gastroparesis in Study VP-VLY-686-3301

Jesse L. Carlin,Christos Polymeropoulos,Michaela Fisher,Paula Moszczynski,Garrett Johannsen,Changfu Xiao,Gunther Birznieks,Mihael Polymeropoulos
DOI: https://doi.org/10.14309/01.ajg.0001038760.41057.62
2024-10-26
The American Journal of Gastroenterology
Abstract:Tradipitant is a novel NK1R antagonist studied in diabetic and idiopathic gastroparesis. This report presents the analysis from the open-label arm of a multicenter, randomized, double-blind, placebo-controlled study (VP-VLY-686-3301) assessing the efficacy of tradipitant in relieving symptoms of gastroparesis.
gastroenterology & hepatology
What problem does this paper attempt to address?